Immunization technologies: Time to consider new preventative solutions for respiratory syncytial virus infections

New technologies for the prevention of infectious diseases are emerging to address unmet medical needs, in particular, the use of long-acting monoclonal antibodies (mAb) to prevent Respiratory Syncytial Virus (RSV) lower respiratory tract disease in infants during their first RSV season. The lack of...

Descripción completa

Detalles Bibliográficos
Autores principales: Weil-Olivier, Catherine, Salisbury, David, Navarro-Alonso, José Antonio, Tzialla, Chryssoula, Zhang, Yan, Esposito, Susanna, Midulla, Fabio, Tenenbaum, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Rsv
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190199/
https://www.ncbi.nlm.nih.gov/pubmed/37193673
http://dx.doi.org/10.1080/21645515.2023.2209000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190199/
https://www.ncbi.nlm.nih.gov/pubmed/37193673
http://dx.doi.org/10.1080/21645515.2023.2209000

Ejemplares similares